Is BBIO stock a Buy, Sell, or Hold?

Based on our analysis, BBIO is currently a HOLD with moderate confidence. 📊 HOLD: BBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BBIO stock?

Our analysis estimates the fair value range for BBIO to be between $68.35 and $76.17. The current price is $68.92.

What is the analyst price target for BBIO?

The average Wall Street analyst price target for BBIO is $101.87. This implies a potential upside of 48.5% from current levels.

BBIO Stock Analysis: Buy, Sell, or Hold?

BBIO - BridgeBio Pharma, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$68.92

0.31 (0.45%) ▲

5d: +2.18%

30d: -11.3%

90d: -9.39%

HOLD

MODERATE Confidence

Protect Your BBIO Gains

Analysis Updated: May 13, 2026 12:00 AM ET

Earnings: May 07, 2026 0d

Smart Money Accumulation

BBIO is down 4.1% this week, but smart money is accumulating calls. Top strike: $75 2026-07-17 with 1,716 OI. Call ratio: 72% View Scanner →

Strength: 4.3/10

Get Alerted When BBIO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$36.78

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$22.84

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BBIO is currently trading at $68.92, which is considered slightly low relative to its 30-day fair value range of $68.35 to $76.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 65.3) compared to its historical average (262.2). Remarkably, the market is currently pricing in an annual earnings decline of 37.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, BBIO is in a strong uptrend. The price is approaching resistance at $70.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: BBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $101.87 (+48.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Historical Trading Range $68.35 - $76.17

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 48.5% below Wall St target ($101.87)

Trading Range Analysis

30-Day Trading Range $68.35 - $76.17

Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $63.88

Resistance Level $70.95

Current Trend Strong Uptrend

Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 65.34

Wall Street Target $101.87 (+48.5%)

Revenue Growth (YoY) 66.8%

Profit Margin -124.4%

Valuation Discount vs History -37.1% cheaper

PE vs Historical 65.3 vs 262.2 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -37.1% (market-implied from PE analysis)

1-Year Target $61.75 (-10%)

2-Year Target $55.57 (-19%)

3-Year Target $50.02 (-27%)

3-Yr Target (if PE normalizes) (PE: 65→262) $200.70 (+193%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 65.3 to 262.2

Stabilization Target: $275.31 (+301.3%)

PE Expansion Potential: +301.3%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: May 14, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:41 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BBIO showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Neil Kumar SELL 40000 shares 2026-04-09

Gilbert Ray Cisneros, Jr. BUY 2026-03-19

Gilbert Ray Cisneros, Jr. BUY 2026-03-18

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BBIO.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BMRN Biomarin Pharmaceutical …	STRONG BUY 29 analysts	$91	60 HOLD
CYTK Cytokinetics Inc	STRONG BUY 21 analysts	$104	59 HOLD
BHVN Biohaven Pharmaceutical …	STRONG BUY 16 analysts	$22	57 HOLD
DNTH Dianthus Therapeutics In…	STRONG BUY 12 analysts	$127	59 HOLD
RVMD Revolution Medicines Inc	STRONG BUY 12 analysts	$181	58 HOLD

BMRN Biomarin Pharmace…

60 HOLD

CYTK Cytokinetics Inc

59 HOLD

BHVN Biohaven Pharmace…

57 HOLD

DNTH Dianthus Therapeu…

59 HOLD

RVMD Revolution Medici…

58 HOLD

Advanced BBIO Option Strategies

Professional options setups generated by AI based on today's BBIO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BBIO

BBIO Technical Chart BBIO Price Prediction BBIO Earnings Date BBIO Investment Advisor BBIO Fair Price Analyzer BBIO Options Advisor BBIO Options Chain BBIO Options Analysis BBIO Competitors

Compare BBIO with Peers

BBIO vs APLS
Which one to buy?

BBIO vs DNLI
Which one to buy?

BBIO vs RVMD
Which one to buy?

BBIO vs IMVT
Which one to buy?

BBIO vs MDGL
Which one to buy?

KRYS vs BBIO

IBRX vs BBIO

ARWR vs BBIO

MDGL vs BBIO
Winner: MDGL

ROIV vs BBIO
Winner: BBIO

Create New Comparison View All Competitors

Tradestie